Long-term follow-up of patients at high risk for nephropathy after contrast exposure

Angiology

Volumn 66, Issue 6, 2015, Pages 514-518

  Abaci, Okay ^a   Harmankaya, Ozlem ^b   Kocas, Betul ^a   Kocas, Cuneyt ^a   Bostan, Cem ^a   Coskun, Ugur ^a   Yildiz, Ahmet ^a   Ersanli, Murat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Department of Orthopaedics and Traumatology   (Turkey)

Author keywords

contrast media exposure; impaired renal function; long term follow up

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE KIDNEY FAILURE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DEATH; DIALYSIS; DRUG EXPOSURE; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; KIDNEY FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; CHEMICALLY INDUCED; DIAGNOSTIC USE; DRUG EFFECTS; KIDNEY; KIDNEY DISEASES; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TIME;

CONTRAST MEDIA; HUMANS; KIDNEY; KIDNEY DISEASES; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84931091130     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714546527     Document Type: Article

References (20)

1. Thom T, Haases N, Rosamond W, et al. Heart disease and stroke statistics - 2006 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2006 ; 113 ((6)). e85 - e151
2. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008 ; 51 ((15)). 1419-1428
3. Levy EM, Viscoli CM, Horwitz RJ. The effect of acute renal failure on mortality: a cohort analysis. JAMA. 1996 ; 275 ((19)). 1489-1494
4. Reddan D, Laville M, Garovic VD. Contrast-induced nephropathy and its prevention: what do we really know from evidence-based findings?. J Nephrol. 2009 ; 22 ((3)). 333-351
5. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 ; 44 ((7)). 1393-1399
6. McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Med. 2006 ; 98 (6A). 5K - 13K
7. Am J Kidney Dis. 2002 ; 39 (2 suppl 1). S1 - S266
8. Schweiger MJ, Chambers CE, Davidson CJ, et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv. 2007 ; 69 ((1)). 135-140
9. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005 ; 68 ((1)). 14-22
10. Sendeski M, Patzak A, Pallone T, Cao C, Persson AE, Persson PB. Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy. Radiology. 2009 ; 251 ((3)). 697-704
11. Haller C, Hizoh I. The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol. 2004 ; 39 ((3)). 149-154
12. Ix JH, McCulloch CE, Chertow GM. Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. Nephrol Dial Transplant. 2004 ; 19 ((11)). 2747-2753
13. Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. Am J Roentgenol. 1981 ; 136 ((5)). 859-861
14. Al-Ghonaim M, Pannu N. Prevention and treatment of contrast induced nephropathy. Tech Vasc Interv Radiol. 2006 ; 9 ((2)). 42-49
15. Gandhi S, Mosleh W, Abdel-Qadir H, Farkouh ME. Statins and contrast-induced acute kidney injury with coronary angiography: systematic review and meta-analysis [published online May 19, 2014]. Am J Med. 2014 ; (14). S0002 00397-9343 0
16. Au TH, Bruckner A, Mohiuddin SM, Hilleman DE. The prevention of contrast-lnduced nephropathy [published online July 3, 2014]. Ann Pharmacother. 2014 ;:
17. Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis. Circulation. 2012 ; 125 ((25)). 3099-3107
18. Solomon R, Mehran R, Natarajan MK, et al. Contrast-induced nephropathy and long-term adverse events: cause and effect?. Clin J Am Soc Nephrol. 2009 ; 4 ((7)). 1162-1169
19. Marenzi G, Lauri G, Campodonico J, et al. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med. 2006 ; 119 ((2)). 155-162
20. Goldenberg I, Chonchol M, Guetta V. Reversible acute kidney injury following contrast exposure and the risk of long-term mortality. Am J Nephrol. 2009 ; 29 ((2)). 136-144